Invention Publication
- Patent Title: Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer
-
Application No.: US17953867Application Date: 2022-09-27
-
Publication No.: US20230248740A1Publication Date: 2023-08-10
- Inventor: Hwan Geun Choi , Jong Bae Park , Eunhwa Ko , Jung Beom Son , Nam Doo Kim , Seung Hoon Lee , Do-Hyun Nam
- Applicant: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION , NATIONAL CANCER CENTER , SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
- Applicant Address: KR Daegu
- Assignee: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION,NATIONAL CANCER CENTER,SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
- Current Assignee: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION,NATIONAL CANCER CENTER,SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
- Current Assignee Address: KR Daegu
- Priority: KR 20170024812 2017.02.24
- The original application number of the division: US16488706 2019.08.26
- Main IPC: A61K31/5513
- IPC: A61K31/5513 ; A61P35/04 ; A61K31/415 ; A61K31/4365 ; A61K31/437 ; A61K31/506 ; A61K31/5377 ; C07K16/22
Abstract:
Disclosed is a pharmaceutical composition for the prevention or treatment of brain cancer, containing a compound capable of penetrating the blood-brain barrier as an active ingredient, the pharmaceutical composition for the prevention or treatment of brain cancer is capable of efficiently penetrating the blood-brain barrier of the brain to thereby effectively inhibit LRRK2 protein expression, and is thus useful in the prevention or treatment of brain cancer.
Information query
IPC分类:
